ReShape Lifesciences (RSLS) News Today $4.38 -0.09 (-2.01%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period ReShape Lifesciences files to sell 2.11M shares of common stock for holdersDecember 20 at 5:23 PM | markets.businessinsider.comQ3 2024 ReShape Lifesciences Inc Earnings CallNovember 16, 2024 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comReShape Lifesciences Reports Q3 Growth and Strategic MovesNovember 16, 2024 | markets.businessinsider.comReshape Lifesciences Inc (RSLS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...November 15, 2024 | finance.yahoo.comReShape Lifesciences Inc. (RSLS) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comReShape Lifesciences receives Health Canada approval for Lap-Band 2.0 FLEXNovember 12, 2024 | markets.businessinsider.comReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate UpdateNovember 12, 2024 | globenewswire.comReShape secures NIH grant to develop electrodes for diabetes treatment deviceNovember 12, 2024 | finance.yahoo.comReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEXNovember 12, 2024 | globenewswire.comReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California's Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape's Proprietary Diabetes Bloc-Stim Neuromodulation™ TechnologyNovember 11, 2024 | globenewswire.comReShape Lifesciences (NASDAQ:RSLS) Stock Passes Above Two Hundred Day Moving Average - Should You Sell?ReShape Lifesciences (NASDAQ:RSLS) Share Price Passes Above 200 Day Moving Average - Here's What HappenedOctober 18, 2024 | marketbeat.comReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Up 472.0% in SeptemberReShape Lifesciences Inc. (NASDAQ:RSLS - Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totalling 57,200 shares, an increase of 472.0% from the September 15th total of 10,000 shares. Currently, 12.2% of the company's stock are sold short. Based on an average daily volume of 157,500 shares, the short-interest ratio is currently 0.4 days.October 10, 2024 | marketbeat.comReShape Lifesciences (NASDAQ:RSLS) Shares Pass Above 200 Day Moving Average - Should You Sell?ReShape Lifesciences (NASDAQ:RSLS) Stock Passes Above 200-Day Moving Average - Here's What HappenedOctober 4, 2024 | marketbeat.comReshape Lifesciences (NASDAQ:RSLS) Stock, Short Interest ReportSeptember 24, 2024 | benzinga.comReshape Lifesciences (NASDAQ:RSLS) Stock Quotes, Forecast and News SummarySeptember 24, 2024 | benzinga.comUpcoming Stock Splits This Week (September 23 to September 27) – Stay InvestedSeptember 23, 2024 | msn.comReShape Lifesciences Announces 1-for-58 Reverse Stock SplitSeptember 19, 2024 | globenewswire.comNexstim Oyj (5NX.MU)August 22, 2024 | finance.yahoo.comQ2 2024 ReShape Lifesciences Inc Earnings CallAugust 16, 2024 | finance.yahoo.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2024 Earnings Call TranscriptAugust 16, 2024 | msn.comRSLS Stock Earnings: Reshape Lifesciences Misses Revenue for Q2 2024August 15, 2024 | markets.businessinsider.comReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate UpdateAugust 13, 2024 | globenewswire.comMaxim Group Downgrades ReShape Lifesciences (RSLS)July 19, 2024 | msn.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHUY, RSLS on Behalf of ShareholdersJuly 19, 2024 | globenewswire.comVyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”July 9, 2024 | globenewswire.comReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad MedisysJuly 9, 2024 | globenewswire.comAmid Ozempic's 'Miracle' Weight-Loss Craze, This Company Peaked Over 100% In Tuesday Pre-Market After Receiving Approval For Obesity TreatmentMay 29, 2024 | msn.comWhy ReShape Lifesciences Stock Is Moving Higher WednesdayMay 29, 2024 | msn.comReShape Lifesciences Inc. (NASDAQ:RSLS) Q1 2024 Earnings Call TranscriptMay 19, 2024 | msn.comQ1 2024 ReShape Lifesciences Inc Earnings CallMay 16, 2024 | finance.yahoo.comReshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 16, 2024 | finance.yahoo.comReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | globenewswire.comReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate UpdateMay 14, 2024 | globenewswire.comReshape Lifesciences Inc RSLSApril 16, 2024 | morningstar.comRSLS ReShape Lifesciences Inc.April 7, 2024 | seekingalpha.comWill GLP-1 medications replace weight loss surgery?April 3, 2024 | msn.comReShape Lifesciences Full Year 2023 Earnings: EPS Beats Expectations, Revenues LagApril 3, 2024 | finance.yahoo.comQ4 2023 ReShape Lifesciences Inc Earnings CallApril 2, 2024 | finance.yahoo.comReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate UpdateApril 1, 2024 | globenewswire.comLatest News for Reshape Lifesciences Stock (NASDAQ:RSLS)March 29, 2024 | benzinga.comReShape Lifesciences Inc: ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemMarch 28, 2024 | finanznachrichten.deReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon SystemMarch 28, 2024 | globenewswire.comReShape Lifesciences sees 55.4% fall in Y/Y expenses in 2024 with cost cut planMarch 4, 2024 | msn.comReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEXMarch 4, 2024 | globenewswire.comReShape Lifesciences Inc (RSLS)February 29, 2024 | investing.comReShape Lifesciences, Inc.February 29, 2024 | edition.cnn.comReShape Lifesciences Inc.February 24, 2024 | thestreet.comReshape Lifesciences Stock (NASDAQ:RSLS) Insider TradesFebruary 22, 2024 | benzinga.comReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEXFebruary 22, 2024 | finance.yahoo.com Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now RSLS Media Mentions By Week RSLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RSLS News Sentiment▼0.590.60▲Average Medical News Sentiment RSLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RSLS Articles This Week▼11▲RSLS Articles Average Week Get ReShape Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RSLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ABT News ISRG News SYK News BSX News MDT News BDX News EW News RMD News IDXX News DXCM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RSLS) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ReShape Lifesciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ReShape Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
